Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qishen Yiqi Dropping Pills in Severe Pulmonary Hypertension
NCT07604805Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Oct 2023
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Qishenyiqi Dripping Pills in pulmonary hypertension (PH) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoints: 6-Minute Walk Distance at 52 weeks, Seattle Angina Questionnaire at 52 weeks and 1 more. Started Oct 2023; status: recruiting.
02
Drugs
Qishenyiqi Dripping Pills
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07604805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07604805.